Badanie nad długoterminowym bezpieczeństwem i skutecznością efgartigimodu u dorosłych z przewlekłą zapalną polineuropatią demielinizacyjną (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a long-term condition that affects the nerves, leading to weakness and numbness. This study focuses on a treatment called efgartigimod, which is given as an injection under the skin. The main goal of the study is to check how safe and tolerable this treatment is over a long period for people with CIDP.

The study involves using efgartigimod in a form that is combined with another substance to help it be absorbed better when injected. Participants will receive this treatment regularly, and the study will monitor their health to see how well they tolerate the medication and if it helps manage their symptoms. Some participants may receive a placebo, which looks like the treatment but does not contain the active substance.

Throughout the study, participants will have regular check-ups to monitor any side effects and to assess the effectiveness of the treatment. The study aims to provide valuable information on the long-term use of efgartigimod for managing CIDP, helping to understand its potential benefits and any risks involved.